|
 Saddle River, NJ— (January 30, 2006) PDI, Inc. (NASDAQ: PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, announced the hiring of Larry Perini as an additional Executive Director in the expanding Business Development Unit of PDI Performance Sales Teams. Perini reports directly to Carl Sailer, Vice President of Marketing and Business Development.
In this new position, Perini will be responsible for identifying and cultivating prospective client relationships necessary to winning new business for Performance Sales Teams. "I had worked with PDI in a client-vendor relationship over the past year or so, and came to have a great deal of respect for the people here and what they have to offer to the marketplace. I am excited to have the opportunity to work with them and to help contribute to their success in the marketplace," said Perini.
Perini brings over 20 years experience in business development, sales management and operations in the information technology industry, selling IT solutions and supporting the pharmaceutical, life sciences and financial services industries. He has worked for Wang Laboratories, Butler International, and Brainshark, Inc. He is a graduate of St. John's University and resides with his family in Yardley, PA.
"Larry Perini is a great asset to our team. Throughout his career he has amassed an impressive track record of achievement by consistently exceeding his sales objectives and driving profitable growth, such as winning the annual President's Award for consistently exceeding revenue and gross profit targets every year of eligibility for seventeen years. This drive and entrepreneurial spirit are well suited to helping us further solidify the PDI Performance Sales Teams solution within our industry," said Carl Sailer.
For more information contact:
Stephen P. Cotugno
Executive Vice President-Corporate Development
PDI, Inc.
201-574-8617
About PDI
PDI, Inc. (NASDAQ: PDII) is a diversified sales and marketing services provider to the biopharmaceutical industry. PDI's comprehensive set of outsourced sales and marketing solutions is designed to increase its clients' strategic flexibility and enhance their efficiency and profitability. Headquartered in Saddle River, NJ, PDI also has offices in Pennsylvania and Illinois.
PDI's sales and marketing services include our Performance Sales Teams™, which are dedicated teams for specific clients; and Select Access™, our targeted sales solution that leverages an existing infrastructure; marketing research and consulting; and medical education and communications. The company's experience extends across multiple therapeutic categories and includes office and hospital-based initiatives.
PDI's commitment is to deliver innovative solutions, unparalleled execution and superior results for its clients. Through strategic partnership and client-driven innovation, PDI maintains some of the longest standing sales and marketing relationships in the industry. Recognized as an industry pioneer, PDI remains committed to continued innovation.
For more information, visit the Company's website at www.pdi-inc.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding future events and financial performance. These statements involve a number of risks and uncertainties and are based on numerous assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control.
Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, changes in our operating expenses, adverse patent rulings, FDA, legal or accounting developments, competitive pressures, failure to meet performance benchmarks in significant contracts, changes in customer and market requirements and standards, the impact of
any stock repurchase programs, and the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2004, and PDI's periodic reports on Form 8-K filed with the Securities and Exchange Commission since January 1, 2005. The forward looking-statements in this press release are based upon
management's reasonable belief as of the date hereof. PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
|
